Shattuck Labs (STTK) Amortization of Deferred Charges (2022 - 2026)
Shattuck Labs' (STTK) quarterly Amortization of Deferred Charges came in at $132000.0 in Q1 2026, up 11.86% year-on-year from $118000.0 in Q1 2025, and little changed on a QoQ basis from $132000.0 in Q4 2025.
Shattuck Labs (STTK) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 5 years of Amortization of Deferred Charges data on file, last reported at $132000.0 in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 11.86% year-over-year to $132000.0 in Q1 2026; TTM through Mar 2026 was $520000.0, a 16.85% increase from a year earlier, with the FY2025 full-year figure at $506000.0, up 18.22% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $132000.0, roughly flat from $132000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for STTK reached as high as $133000.0 in Q3 2025 and fell as low as $65000.0 in Q1 2022.
- Historically, Amortization of Deferred Charges has averaged $101882.4 across 5 years, with a median of $101000.0 in 2024.
- Across the five-year window, Amortization of Deferred Charges soared 30.77% in 2023 and climbed 11.86% in 2026, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $82000.0 in 2022, then increased by 18.29% to $97000.0 in 2023, then gained by 16.49% to $113000.0 in 2024, then climbed by 16.81% to $132000.0 in 2025, then changed by 0.0% to $132000.0 in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $132000.0 in Q1 2026, $132000.0 in Q4 2025, and $133000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Shattuck Labs | 831.66 Mn | 831.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132,000.00 |
| Mar 31, 2026 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 123,000.00 |
| Jun 30, 2025 | 123,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Dec 31, 2023 | 97,000.00 |
| Dec 31, 2023 | 97,000.00 |